PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.98%
Revenue growth above 1.5x ADI's 1.67%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
11.21%
Gross profit growth above 1.5x ADI's 1.82%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
25.22%
EBIT growth above 1.5x ADI's 4.44%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
25.22%
Operating income growth above 1.5x ADI's 4.44%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
27.21%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
30.95%
EPS growth of 30.95% while ADI is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
28.57%
Diluted EPS growth of 28.57% while ADI is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
-1.39%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.43%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.53%
Dividend growth under 50% of ADI's 1.85%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
70.49%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
90.47%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
59.81%
10Y revenue/share CAGR under 50% of ADI's 138.77%. Michael Burry would suspect a lasting competitive disadvantage.
96.53%
5Y revenue/share CAGR 1.25-1.5x ADI's 75.07%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
37.60%
3Y revenue/share CAGR above 1.5x ADI's 12.24%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
205.28%
10Y OCF/share CAGR at 75-90% of ADI's 258.48%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
226.83%
5Y OCF/share CAGR at 50-75% of ADI's 384.43%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
98.43%
3Y OCF/share CAGR above 1.5x ADI's 34.64%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-50.56%
Negative 10Y net income/share CAGR while ADI is at 192.30%. Joel Greenblatt sees a major red flag in long-term profit erosion.
397.85%
5Y net income/share CAGR 1.25-1.5x ADI's 339.49%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
68.28%
Positive short-term CAGR while ADI is negative. John Neff would see a clear advantage in near-term profit trajectory.
92.20%
10Y equity/share CAGR at 50-75% of ADI's 180.89%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
21.10%
Positive 5Y equity/share CAGR while ADI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
5.44%
Positive short-term equity growth while ADI is negative. John Neff sees a strong advantage in near-term net worth buildup.
288.56%
Dividend/share CAGR of 288.56% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
278.60%
Dividend/share CAGR of 278.60% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
286.61%
3Y dividend/share CAGR 1.25-1.5x ADI's 207.01%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
6.64%
AR growth well above ADI's 5.65%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.83%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-2.11%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-1.74%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
-1.63%
Our R&D shrinks while ADI invests at 1.28%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.18%
SG&A declining or stable vs. ADI's 10.03%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.